Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

Non-interventional Study of Patients With Transthyretin (ATTR) AmyloidosisRecruiting
NCT06465810N/AUpdated Aug 19, 2026
Sponsor: AstraZeneca
Transthyretin Amyloidosis · ATTR-CM · ATTRv-PN · ATTR
United States, Canada, China, Germany, Spain +1 more
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
NCT06655896Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Scleroderma, Diffuse
United States, Argentina, Australia, Austria, Belgium +17 more
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFActive Not Recruiting
NCT06237335Phase 2Updated Aug 19, 2026
Sponsor: ReCode Therapeutics
Cystic Fibrosis
United States, France, Netherlands, New Zealand, United Kingdom
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabActive Not Recruiting
NCT05142696Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Extensive Stage Small Cell Lung Cancer
United States, Austria, Canada, China, Czechia +7 more
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"Not Yet Recruiting
NCT07281027Phase 3Updated Aug 19, 2026
Sponsor: Yale University
New Onset Refractory Status Epilepticus · New-Onset Refractory Status Epilepticus · Febrile Infection-Related Epilepsy Syndrome (FIRES)
United States, Canada, France, Italy, South Korea +2 more
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Active Not Recruiting
NCT06782373Phase 2Updated Aug 19, 2026
Sponsor: Swedish Orphan Biovitrum
VEXAS · VEXAS Syndrome
United States, Canada, France, Germany, Italy +3 more
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)Active Not Recruiting
NCT04411654Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Prevail Therapeutics
Gaucher Disease, Type 2
United States, United Kingdom
Post Market Study of Cerament V/G in Pedal OsteomyelitisCompleted
NCT06628115NAUpdated Aug 19, 2026
Sponsor: Mid and South Essex NHS Foundation Trust
Osteomyelitis - Foot
United Kingdom
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsRecruiting
NCT06549595Phase 3Updated Aug 19, 2026
Sponsor: AstraZeneca
Untreated Follicular Lymphoma
United States, Australia, Belgium, Brazil, Canada +18 more
Understanding (Poly)Phenol Metabolism in People With an IleostomyRecruiting
NCT07772362NAUpdated Aug 19, 2026
Sponsor: University of Ulster
Ileostomy - Stoma
United Kingdom
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular AtrophyRecruiting
NCT07287982Phase 2Updated Aug 19, 2026
Sponsor: argenx
Spinal Muscular Atrophy (SMA)
United States, United Kingdom
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaActive Not Recruiting
NCT05196035Phase 3Updated Aug 19, 2026
Sponsor: Bayer
Chronic Kidney Disease · Proteinuria
United States, Argentina, Australia, Austria, Belgium +27 more
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaRecruiting
NCT06137118Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: AstraZeneca
B-cell Acute Lymphoblastic Leukemia (B-ALL)
United States, Australia, Brazil, Canada, China +8 more
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)Recruiting
NCT05489705N/AUpdated Aug 19, 2026
Sponsor: Bristol-Myers Squibb
Obstructive Hypertrophic Cardiomyopathy
United States, Austria, Czechia, France, Germany +4 more
A Study to Identify Breast Cancer (IDBC)Recruiting
NCT04495244N/AUpdated Aug 19, 2026
Sponsor: Syantra Inc.
Breast Cancer Female
Canada, South Korea, United Kingdom
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruiting
NCT07472517Phase 3Updated Aug 19, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer (SCLC) · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
United States, Argentina, Australia, Austria, Belgium +37 more
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic LeukemiaRecruiting
NCT07277231Phase 3Updated Aug 19, 2026
Sponsor: BeOne Medicines
Chronic Lymphocytic Leukemia
United States, Australia, Brazil, Canada, China +12 more
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruiting
NCT05222529Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
Bulgaria, Colombia, Guatemala, Hungary, Poland +3 more
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A AdultsActive Not Recruiting
NCT04370054Phase 3Updated Aug 19, 2026
Sponsor: Pfizer
Hemophilia A
United States, Australia, Brazil, Canada, France +11 more
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive Not Recruiting
NCT04644068Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: AstraZeneca
Ovarian Cancer · Breast Cancer · Pancreatic Cancer · Prostate Cancer
United States, Australia, Canada, China, Czechia +9 more
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver DiseaseRecruiting
NCT04873258N/AUpdated Aug 19, 2026
Sponsor: Richmond Research Institute
Healthy · Fatty Liver · MASLD · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
United Kingdom
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee ArthroplastyRecruiting
NCT07214311Phase 2, Phase 3Updated Aug 19, 2026
Sponsor: Peptilogics
Prosthetic-joint Infection
United States, United Kingdom
Open-Label Extension Study to Assess GLM101 in PMM2-CDG PatientsEnrolling By Invitation
NCT06657859Phase 2Updated Aug 19, 2026
Sponsor: Glycomine, Inc.
Pmm2-CDG · Phosphomannomutase 2 Deficiency
United States, Czechia, France, Germany, Italy +3 more
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive Not Recruiting
NCT05648968Phase 3Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Argentina, Australia, China, France +11 more
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1Enrolling By Invitation
NCT07008469Phase 3Updated Aug 19, 2026
Sponsor: Avidity Biosciences, Inc.
Myotonic Dystrophy Type 1 · DM1 · Myotonic Dystrophy · Myotonia
United States, Canada, Denmark, France, Germany +5 more

Previous page Next page